SG
Smriti Gulwady
About Smriti Gulwady
Data last updated:
Smriti Gulwady is a Director at Sanmour Pharma Private Limited (since 2007), Designated Partner at Roumnas Biolife Llp (since 2025) and Designated Partner at Sanmour Consulting Llp (since 2014). The companies operate in Pharma and Research & Development. The largest current company by reported revenue is Sanmour Pharma Private Limited at ₹7,000 (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sanmour Pharma Private Limited U85195MH2005PTC158160 | Director | 01 Oct 2007 | 2005 | ₹7,000 (FY 2024) | Under Process Of Striking Off |
 Roumnas Biolife Llp ACL-5725 | Designated Partner | 24 Jan 2025 | 2025 | Active | |
| Sanmour Consulting Llp AAC-6689 | Designated Partner | 04 Sep 2014 | 2014 | Active |
Board colleagues of Smriti Gulwady
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ram Gulwady | 00147906 | Sanmour Pharma Private Limited , Roumnas Biolife Llp and 1 more | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Smriti Gulwady
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Smriti Gulwady
Smriti Gulwady currently holds 3 directorships: Sanmour Pharma Private Limited (Director, since 01 Oct 2007, revenue ₹7,000 (FY 2024)); Roumnas Biolife Llp (Designated Partner, since 24 Jan 2025); Sanmour Consulting Llp (Designated Partner, since 04 Sep 2014).
Smriti Gulwady was first appointed on 01 Oct 2007 as Director at Sanmour Pharma Private Limited. The most recent appointment on record is 24 Jan 2025 at Roumnas Biolife Llp.
The current boards of Smriti Gulwady's companies include Ram Gulwady (Sanmour Pharma Private Limited).